Literature DB >> 3100753

Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome.

M Kobayashi, H Morishita, N Sugiyama, K Yokochi, M Nakano, Y Wada, Y Hotta, A Terauchi, I Nonaka.   

Abstract

Muscle biopsy specimens from two patients with MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) were studied biochemically. 14CO2 production rates from (1-14C)pyruvate, (U-14C)malate, and (1-14C)2-ketoglutarate were all decreased in intact mitochondria in both patients. Rotenone-sensitive NADH cytochrome c reductase activities were decreased to 8% (patient 1) and 6% (patient 2) of control values; succinate cytochrome c reductase and cytochrome c oxidase values were within normal limits. These results indicate that both patients have a defect of NADH-CoQ reductase of the respiratory chain and that MELAS can be brought about by a defect of NADH-CoQ reductase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100753     DOI: 10.1016/s0022-3476(87)80158-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Melas syndrome.

Authors:  S K Singh; D Sarin; J M Puliyel; R Srivastav; R Gupta; N Kumar; A Mathews
Journal:  Indian J Pediatr       Date:  1999 Jul-Aug       Impact factor: 1.967

Review 2.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

3.  Defective pattern of mitochondrial respiratory enzymes in mitochondrial myopathy.

Authors:  S Miyabayashi; K Haginoya; H Hanamizu; K Iinuma; K Narisawa; K Tada
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 4.  Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.

Authors:  J A Morgan-Hughes; A H Schapira; J M Cooper; J B Clark
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

5.  An unusual patient with the neonatal Marfan phenotype and mitochondrial complex I deficiency.

Authors:  J Christodoulou; R Petrova-Benedict; B H Robinson; V Jay; J T Clarke
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

Review 6.  Molecular basis of mitochondrial DNA disease.

Authors:  M D Brown; D C Wallace
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

7.  Isolated and combined deficiencies of NADH dehydrogenase (complex I) in muscle tissue of children with mitochondrial myopathies.

Authors:  G C Korenke; H A Bentlage; W Ruitenbeek; R C Sengers; W Sperl; J M Trijbels; F J Gabreels; F A Wijburg; V Wiedermann; F Hanefeld
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

8.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Authors:  Rohit Sharma; Bryn Reinstadler; Kristin Engelstad; Owen S Skinner; Erin Stackowitz; Ronald G Haller; Clary B Clish; Kerry Pierce; Melissa A Walker; Robert Fryer; Devin Oglesbee; Xiangling Mao; Dikoma C Shungu; Ashok Khatri; Michio Hirano; Darryl C De Vivo; Vamsi K Mootha
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

9.  Mitochondrial encephalomyopathy (MELAS) with mental disorder. CT, MRI and SPECT findings.

Authors:  T Suzuki; J Koizumi; H Shiraishi; N Ishikawa; K Ofuku; M Sasaki; T Hori; N Ohkoshi; I Anno
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

10.  Stroke, hemiparesis and deficient mitochondrial beta-oxidation.

Authors:  L Vallée; M Fontaine; J P Nuyts; G Ricart; I Krivosic; P Divry; C Vianey-Saban; M Lhermitte; J Vamecq
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.